Falsely high B‐type natriuretic peptide concentration in patients without heart failure attributed to AxSYM assay: case series of eight subjects

We report a case series of eight subjects complaining of non‐specific chest pain without heart failure, but with apparent high concentrations of plasma B‐type natriuretic peptide (BNP). No positive clinical characteristics were identified in physical examinations, cardiac imaging, laboratory finding...

Full description

Saved in:
Bibliographic Details
Published in:ESC Heart Failure 2015-03, Vol.2 (1), p.37-39
Main Authors: Jin, Cai De, Kim, Moo Hyun, Guo, Long Zhe, Li, Shu Hua, Han, Jin‐Yeong
Format: Article
Language:English
Subjects:
Amino acids
Automated‐immunoassay comparison
Automation
Biomarkers
Blood pressure
B‐type natriuretic peptide
Case Report
Chronic obstructive pulmonary disease
Diabetes
Enzymes
Heart failure
Hypertension
Immunoassay
Immunoglobulins
Medical imaging
Outpatient care facilities
Peptides
ProBNP N‐terminus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:We report a case series of eight subjects complaining of non‐specific chest pain without heart failure, but with apparent high concentrations of plasma B‐type natriuretic peptide (BNP). No positive clinical characteristics were identified in physical examinations, cardiac imaging, laboratory findings, or pulmonary function tests. However, we observed unusually high BNP values when analysing blood samples of the patients using the AxSYM assay, and this was not supported by readings from Triage® or ADVIA Centaur® assays on the same samples, which showed BNP within the normal range. We believe that the possibility for false readings for high BNP levels in healthy individuals measured by AxSYM assay should be taken into account by physicians in clinical practice to avoid medical errors.
ISSN:2055-5822
2055-5822
DOI:10.1002/ehf2.12024